Upload Avatar (500 x 500)
Dabing Huang
Mayo Clinic College of Medicine
University of Science and Technology of China
Anhui
Language: Chinese, English
Organoids
Organ-On-A-Chip
Tumor Microenvironment
Malignant Tumors
Pathogenesis
Treatment Resistance
Non-Coding Rna
Targeted Therapy
Immunotherapy
Clinical Applications
Areas of Focus
- Research on malignant tumor pathogenesis and treatment resistance using organoids and organ-on-a-chip
- Molecular mechanisms and clinical applications of non-coding RNA in cancer treatment resistance
- Molecular mechanisms and clinical applications of targeted therapy resistance in cancer
- Molecular mechanisms and clinical applications of immunotherapy resistance in cancer
Work Experience
- 2019/12 - Present: Associate Chief Physician, First Affiliated Hospital of University of Science and Technology of China
- 2018/01 - 2019/11: Attending Physician, First Affiliated Hospital of University of Science and Technology of China
- 2014/12 - 2017/12: Attending Physician, Anhui Provincial Hospital, Anhui Medical University
- 2009/07 - 2014/11: Physician, Anhui Provincial Hospital, Anhui Medical University
Academic Background & Achievements
- 2019/07 - 2023/10 Postdoctoral: University of Science and Technology of China, Department of Life Sciences and Medicine
- 2014/09 - 2017/12 PhD in Clinical Medicine: Shandong University
- 2006/09 - 2009/07 Master's in Geriatric Medicine: Anhui Medical University
- 2001/09 - 2006/07 Bachelor's in Clinical Medicine: Anhui Medical University
- Member of the expert database for science and technology project evaluation of the Anhui Provincial Department of Science and Technology
- Member of the expert database for degree thesis evaluation of the Ministry of Education
Publications
- V-Set and immunoglobulin domain containing (VSIG) proteins as emerging immune checkpoint targets for cancer immunotherapy., Xia Zhou, Sohail Khan, Dabing Huang, Lu Li, 2022
- LAMTOR5-AS1 regulates chemotherapy-induced oxidative stress by controlling the expression level and transcriptional activity of NRF2 in osteosarcoma cells., Pu YG, Tan YA, Zang CB, Zhao FF, Cai CF, Kong LS, Deng H, Chao FM, Xia R, Xie MH, Ge FF, Pan YY, Cai SB, Huang DB, 2021
- Tumor-associated mesenchymal stem cells promote hepatocellular carcinoma metastasis via a DNM3OS/KDM6B/TIAM1 axis., Wang W, Wang Q, Huang DB, Sun QK, Wu SS, Zhao YJ, Jia W, Hu DS, He YF, 2021
- Paraoxonase 3 is involved in the multi-drug resistance of esophageal cancer., Huang D, Wang Y, He Y, Wang G, Wang W, Han X, Sun Y, Lin L, Shan B, Shen G, Cheng M, Bian G, Fang X, Hu S, Pan Y, 2018
- MiR-20a-5p promotes radio-resistance by targeting Rab27B in nasopharyngeal cancer cells., Huang D, Bian G, Pan Y, Han X, Sun Y, Wang Y, Shen G, Cheng M, Fang X, Hu S, 2017
Awards
- Anhui Provincial Science and Technology Progress Award (2016): Second Prize, Rank 4
- Anhui Provincial Science and Technology Progress Award (2012): Second Prize, Rank 5
